These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19580372)

  • 1. Parental attitudes toward new dosage forms of desloratadine in an online survey: results from four European countries.
    Valovirta E; Scadding G
    Curr Med Res Opin; 2009 Aug; 25(8):2061-7. PubMed ID: 19580372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric allergy medications: review of currently available formulations.
    Scadding G
    Curr Med Res Opin; 2009 Aug; 25(8):2069-79. PubMed ID: 19580371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of desloratadine on conjunctival allergen challenge-induced ocular symptoms.
    Torkildsen GL; Gomes P; Welch D; Gopalan G; Srinivasan S
    Clin Exp Allergy; 2009 Jul; 39(7):1052-9. PubMed ID: 19302250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis.
    Sullivan PW; Navaratnam P; Lorber R; Shekar T
    Curr Med Res Opin; 2010 Jun; 26(6):1389-97. PubMed ID: 20384438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis.
    Dizdar EA; Sekerel BE; Keskin O; Kalayci O; Adalioglu G; Dogan C; Tuncer A
    Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):843-9. PubMed ID: 17346807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
    Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of desloratadine in children between 2 and 11 years of age.
    Gupta S; Khalilieh S; Kantesaria B; Banfield C
    Br J Clin Pharmacol; 2007 May; 63(5):534-40. PubMed ID: 17488362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F; Zieglmayer UP; Zieglmayer R; Kavina A; Marschall K; Munzel U; Petzold U
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults.
    Gupta SK; Kantesaria B; Banfield C; Wang Z
    Br J Clin Pharmacol; 2007 Aug; 64(2):174-84. PubMed ID: 17324243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
    Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
    Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
    Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE; White MV;
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Kruszewski J; Kłos K; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.